Skip to main content

Market Overview

12 Health Care Stocks Moving In Thursday's Intraday Session

Share:
12 Health Care Stocks Moving In Thursday's Intraday Session

 

Gainers

  • Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of Rhythm Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $388.0 million.
  • GT Biopharma (NASDAQ:GTBP) shares moved upwards by 12.11% to $3.61. As of 12:30 EST, this security is trading at a volume of 330.7K shares, making up 140.7% of its average full-day volume over the last 100 days. The company's market cap stands at $110.4 million.
  • Also check out: Insiders Sell More Than $92M Of 4 Stocks
  • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares increased by 11.94% to $1.78. The market value of their outstanding shares is at $14.9 million.
  • Masimo (NASDAQ:MASI) shares increased by 10.89% to $159.91. As of 12:30 EST, this security is trading at a volume of 1.9 million shares, making up 424.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.8 billion. As per the press release, Q4 earnings came out 2 days ago.
  • Catalyst Biosciences (NASDAQ:CBIO) shares increased by 9.72% to $0.57. Trading volume for Catalyst Biosciences's stock is 1.2 million as of 12:30 EST. This is 127.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.8 million.
  • Citius Pharmaceuticals (NASDAQ:CTXR) shares moved upwards by 9.03% to $1.81. Citius Pharmaceuticals's stock is trading at a volume of 2.0 million shares as of 12:30 EST. This is 129.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $264.3 million.

 

Losers

  • Marker Therapeutics (NASDAQ:MRKR) shares decreased by 24.9% to $0.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 201.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.5 million. As per the press release, Q4 earnings came out yesterday.
  • Yumanity Therapeutics (NASDAQ:YMTX) stock declined by 17.52% to $1.46. Trading volume for Yumanity Therapeutics's stock is 197.8K as of 12:30 EST. This is 175.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $15.0 million.
  • Zynex (NASDAQ:ZYXI) stock fell 17.41% to $5.98. As of 12:30 EST, this security is trading at a volume of 951.2K shares, making up 309.1% of its average full-day volume over the last 100 days. The company's market cap stands at $239.7 million.
  • Hillstream BioPharma (NASDAQ:HILS) shares declined by 16.67% to $2.05. As of 12:30 EST, this security is trading at a volume of 271.0K shares, making up 30.5% of its average full-day volume over the last 100 days. The company's market cap stands at $23.0 million.
  • Poseida Therapeutics (NASDAQ:PSTX) stock fell 12.59% to $3.68. Trading volume for this security as of 12:30 EST is 157.4K, which is 98.1% of its average full-day volume over the last 100 days. The company's market cap stands at $230.0 million.
  • Tempest Therapeutics (NASDAQ:TPST) shares decreased by 12.51% to $3.15. The market value of their outstanding shares is at $21.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

 

Related Articles (BLCM + CBIO)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com